Report Indicates Central Florida as Leprosy Hotspot
![]() |
Report Indicates Central Florida as Leprosy Hotspot |
When a 54-year-old landscaper visited an Orlando dermatology clinic with a patchy, painful rash, Dr. Rajiv Nathoo conducted multiple biopsies, seeking answers to the perplexing condition. The rash's relentless advance from the man's limbs to his face had confounded prior medical professionals.
The biopsy outcomes confirmed Dr. Nathoo's intuition, leading to a diagnosis that appeared right out of medical textbooks: leprosy.
Strangely, the man lacked the typical risk factors associated with this elusive infection. Noticing a series of related cases in the vicinity, Dr. Nathoo, a dermatologist and the complex clinic director at Advanced Dermatology and Cosmetic Surgery Clinics in Orlando, began to suspect that Central Florida might unexpectedly be a hotspot for leprosy.
Presently, Dr. Nathoo's team is alerting fellow healthcare providers to remain vigilant for similar instances in the region.
As detailed in a research letter published by Dr. Nathoo and colleagues in the journal Emerging Infectious Diseases, Central Florida has reported some of the highest leprosy rates in the United States.
In 2020, the nation reported a total of 159 cases, a fraction of the 200,000 new annual cases worldwide, as noted by the World Health Organization. Notably, the research letter highlights that Central Florida alone accounted for 81% of Florida's cases and nearly one-fifth of all leprosy cases nationwide.
Labeled as Hansen's disease, leprosy emerges from the Mycobacterium leprae bacteria, which targets nerves beneath the skin.
Although the precise transmission method remains unclear, the prevailing belief suggests that it propagates through droplets expelled when an infected person sneezes or coughs. Prominent symptoms encompass lesions and rashes lacking sensation due to nerve involvement.
For all latest news, follow Top Headline News Google News channel
The bacteria can also find a home in nine-banded armadillos within the Southeastern United States. Genetic studies have connected human infections to leprosy strains harbored by armadillos, yet the mode of human exposure to these bacteria often remains obscure. Curiously, many patients cannot recall any interaction with these creatures.
Casual contact, such as handshakes or proximity to an infected individual, doesn't facilitate transmission. Instead, spread requires prolonged and intimate contact with an untreated leprosy patient over extended periods, according to the US Centers for Disease Control and Prevention. Roughly 95% of individuals possess innate immunity against the infection due to genetically programmed resistance.
As a result, leprosy remains an uncommon ailment in the United States. Typically, cases involve individuals who have traveled to nations with high disease rates or those exposed to disease-carrying armadillos.
However, there are instances where doctors remain uncertain about the source of exposure.
"In certain regions, case numbers are more prevalent. Florida is a notable example," stated Dr. Linda Adams, head of the laboratory research division at the National Hansen's Disease Program, a federal initiative coordinating treatment for diagnosed Americans.
"In these areas, we encounter unexplained cases. Some patients haven't traveled abroad or encountered armadillos."
A 54-year-old individual featured in the recent report informed his physicians that he had never left Florida, lacked exposure to armadillos, and had minimal interaction with individuals from high leprosy prevalence countries, despite spending significant time outdoors.
![]() |
Image Source: edition.cnn.com |
Between 2015 and 2020, around 34% of new cases exhibited no conventional risk factors, according to the research publication. Instead, these individuals seemed to contract the disease locally, indicating leprosy's potential endemism in Florida.
Experts concur on leprosy's gradual endemic nature in the region. However, this should not trigger public health alarm, explained Dr. Nicole Iovine, chief hospital epidemiologist at the University of Florida Health Shands Hospital. The term "endemic" reflects consistent disease levels in a region, not necessarily a surge in rates.
Nathoo noted, "It's still quite rare. The numbers remain relatively low. Our level of concern is minimal."
However, Nathoo has meticulously traced clinical records documenting 15 verified leprosy cases concentrated in the eastern regions of Orlando and Volusia County within the last five years. Out of these, fourteen individuals have not ventured beyond the United States' borders, and there is no discernible link among any of them.
While there exists a pronounced geographic inclination toward the ailment in central Florida, Dr. Charles Dunn, a co-author of the study and chief resident at Advanced Dermatology and Cosmetic Surgery Clinics, pointed out a misconception held by doctors.
The misconception revolves around the belief that leprosy exclusively affects foreign-born individuals or those with direct exposure to nine-banded armadillos.
Considering that their patients lacked these conventional risk factors, Dunn emphasizes the importance of dispelling such assumptions. He highlights that despite armadillos being the conventional example, the medical community struggles to pinpoint a perfect carrier for leprosy. This is because most people do not maintain prolonged contact with nine-banded armadillos.
Dunn stated, "That's the core message of our research, to convey that a patient walked into our clinic, received a diagnosis, and when we reviewed our Florida database, we noticed a clustering effect here."
Nonetheless, the emergence of a potential cluster of endemic cases in Central Florida raises concerns for Iovine. If left untreated, leprosy can lead to paralysis of extremities, vision loss, and the shortening of fingers and toes. While the disease is curable, the treatment involves a prolonged course of antibiotics spanning several years.
Moreover, a cure may not fully address complications like nerve or skin damage in cases where diagnosis has been delayed, a common scenario in the U.S. where the disease isn't frequently encountered by medical professionals.
One of the notable challenges with leprosy lies in the slow growth rate of the bacteria. Depending on the infection type, it may take up to two decades for symptoms such as pale numb patches, rashes, ulcers, and lesions to manifest, as outlined by the CDC.
Due to this prolonged incubation period, identifying the source and transmission of a leprosy infection can be intricate. Given that most medical practitioners "will rarely encounter a leprosy case," Iovine highlighted that initial misdiagnosis is quite common.
"I'm certain that patients go through months without a correct diagnosis," she noted. "I'd say that's more often the norm."
The recent study's case analysis showcased a patient who displayed clinical indications of leprosy over a span of five years prior to seeking consultation with Nathoo and undergoing screening for Hansen's disease. Prior to this, several healthcare providers had conveyed uncertainty regarding his condition.
Upon detecting leprosy, medical practitioners are obligated to promptly notify the state health department within a 24-hour window. Subsequently, the National Hansen's Disease Program dispatches specialized antibiotics to the provider's office and initiates a meticulous process of contact tracing.
"The manifestations of leprosy frequently go unnoticed, making it a relatively overlooked concern for dermatologists," explained Adams. "It doesn't typically register as the primary consideration when confronted with such presentations."
Brenda Goodman of CNN made a significant contribution to this report.
0 Comments